Annals ofHematology

Volume: 6 - Number: 46 - January 15, 2006

Outstanding

Functional assessment and specific depletion of alloreactive human T cells using flow cytometry

Hodgkin disease: the sword of Damocles resheathed

Interfering with amyloidosis

Juvenile myelomonocytic leukemia

BLOOD WORK

Juvenile myelomonocytic leukemia

Clinical and Therapeutics Observations

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

INSIDE BLOOD

IgM memory B cells: origin, mutation, and mobilization by polysaccharide vaccination

Hodgkin disease: the sword of Damocles resheathed

One step closer to gene therapy for hemoglobinopathies

Interfering with amyloidosis

Blood and Runx1: got to have it, really need it

Time to end the stem cell wars?

Depletion of alloreactive T cells: which cell?

Leukemia gene expression: MLL rearrangements in AML and ALL

Genetic rearrangements beget genomic instability

Stress" and sickle red cell adhesion

Plenary Article

Functional assessment and specific depletion of alloreactive human T cells using flow cytometry

PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain

Successful correction of the human -thalassemia major phenotype using a lentiviral vector

Review Articles

Mechanisms of WASp-mediated hematologic and immunologic disease